Global Trolley-mounted Oxygen Therapy System Market Size By Type (With Oxygen Mask, With Oxygen Cylinde), By Application (Hospital, Household), By Region, And Segment Forecasts, 2023 to 2032

The Global Trolley-mounted Oxygen Therapy System Market was valued at USD 2.1 billion in 2023 and is projected to surpass USD 4.0 billion by 2031, growing at a CAGR of 8.2% during the forecast period of 2023 to 2031. This growth is primarily attributed to the increasing incidence of respiratory disorders, a growing geriatric population, and the rising demand for portable oxygen solutions across hospitals, emergency services, and homecare settings. These systems offer a mobile, user-friendly solution to deliver oxygen therapy to patients requiring respiratory assistance, thus playing a vital role in acute and chronic care.

Drivers:

1. Growing Prevalence of Chronic Respiratory Diseases:

The increasing global burden of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory ailments is driving the demand for reliable and portable oxygen therapy systems, including trolley-mounted solutions.

2. Expansion of Home Healthcare Services:

Rising healthcare costs and patient preference for home-based treatments are pushing healthcare providers to adopt portable and user-friendly medical devices, boosting the market for trolley-mounted oxygen therapy systems.

3. Increasing Demand from Emergency Medical Services:

Emergency responders rely heavily on mobile oxygen delivery systems for rapid intervention during critical care scenarios, which significantly supports market expansion.

Restraints:

1. High Cost of Advanced Systems:

While trolley-mounted oxygen systems offer advanced features and portability, their high acquisition and maintenance costs can limit adoption, particularly in resource-constrained settings.

2. Regulatory Compliance and Certification Challenges:

Meeting stringent regulatory standards and ensuring consistent product quality can pose challenges for manufacturers, potentially slowing product launches and global market penetration.

Opportunity:

1. Technological Advancements in Oxygen Delivery Systems:

The development of lighter, more efficient, and digitally integrated oxygen therapy devices presents an opportunity for companies to expand their product portfolios and reach.

2. Expansion in Emerging Markets:

Emerging economies are witnessing rising healthcare investments and a growing awareness of chronic respiratory care, offering lucrative growth avenues for market players.

Market by System Type Insights:

Among the system types, High-Flow Trolley-mounted Oxygen Systems accounted for the largest market share in 2023. These systems are widely used in critical care settings where higher concentrations of oxygen are required, such as during surgical recovery or emergency response. Meanwhile, Low-Flow Trolley-mounted Systems are gaining traction in homecare and outpatient use, driven by their portability and ease of operation.

Market by End-use Insights:

In 2023, the Hospitals & Clinics segment held the largest market share due to the high frequency of respiratory interventions and availability of infrastructure to support such devices. The Homecare segment is expected to grow at the fastest pace through 2031, bolstered by the global shift toward decentralized healthcare and growing preference for in-home respiratory therapy.

Market by Regional Insights:

Geographically, North America dominated the market in 2023, driven by its advanced healthcare infrastructure, high prevalence of respiratory disorders, and increased adoption of home oxygen therapy. Asia-Pacific is anticipated to experience the fastest growth during the forecast period, propelled by improving healthcare access, rising geriatric population, and increasing air pollution levels contributing to respiratory illnesses.

Competitive Scenario:

Key players in the Global Trolley-mounted Oxygen Therapy System Market include Philips Respironics, Invacare Corporation, Drive DeVilbiss Healthcare, Chart Industries, Inc., GCE Group, O2 Concepts, ResMed Inc., and Inogen, Inc. These companies are investing in R&D, product innovations, and global expansion strategies to solidify their market presence.

Scope of Work – Global Trolley-mounted Oxygen Therapy System Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.0 billion

CAGR (2023–2031) 8.2%

Market Segments System Type, End-Use, Region

Growth Drivers Increasing respiratory disease burden, rising demand for mobile and home oxygen therapy

Opportunities Technological innovation, emerging market expansion

Key Market Developments:

2023: Philips Respironics launched an advanced smart trolley-mounted system featuring IoT-enabled monitoring for real-time oxygen saturation and usage analytics.

2024: Drive DeVilbiss Healthcare expanded into Southeast Asia with a new line of compact, rechargeable trolley-mounted oxygen systems designed for home and clinic use.

2025: Inogen Inc. partnered with a major Asian distributor to enhance its presence in developing countries with increasing respiratory care needs.

FAQs:

1) What is the current market size of the Global Trolley-mounted Oxygen Therapy System Market?

The market size was USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Trolley-mounted Oxygen Therapy System Market?

The major driver is the rising prevalence of respiratory conditions like COPD and asthma, along with increased demand for home and emergency oxygen therapy solutions.

3) Which is the largest region during the forecast period in the Global Trolley-mounted Oxygen Therapy System Market?

North America leads the market